Product Information

ERY 2% PADS is a generic product labeled by Padagis Israel Pharmaceuticals Ltd, priced at $1.2428 per EA under NDC 45802096272. Its NADAC has been published 390 times since Nov 28, 2013.

FDA first approved this application on Jul 3, 1996. Its Orange Book therapeutic-equivalence code is AT.

ERY 2% PADS

Erythromycin
$1.2428per EA

Strength

20 mg/mL

NDC

45802096272

Classification

Generic

Dosage Form

SWAB

Route

TOPICAL

Effective Date

10/21/2026

Active Ingredients

ERYTHROMYCIN

Approval Type

Generic (ANDA)

FDA Application

ANDA064126

FDA Approved

7/3/1996

TE Code

AT

On Market Since

7/7/2008

Pharmacological Classes

Decreased Sebaceous Gland Activity
Macrolide Antimicrobial
Macrolide
Macrolides

Price Statistics

The NADAC for ERY 2% PADS has been published 390 times since Nov 28, 2013, and over the history we have for it it has risen 23.5%. The table below summarizes its recorded NADAC range and movement.

Current price$1.2428 per EA
All-time high$1.2428 (Nov 11, 2026)
All-time low$0.8571 (May 17, 2017)
52-week high$1.2428
52-week low$1.2148
Median price$1.0084
Average price$1.0536
Largest weekly change+28.8% (Apr 17, 2024)
Weeks tracked390
Tracking sinceNov 28, 2013

Price History

1W

0.0%

1M

+0.6%

3M

+1.0%

6M

+0.4%

1Y

+2.0%

3Y

+31.8%

5Y

+31.8%

All

+23.5%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Erythromycin market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of ERY 2% PADS?

The current National Average Drug Acquisition Cost (NADAC) for ERY 2% PADS, manufactured by Padagis Israel Pharmaceuticals Ltd, is $1.2428 per EA (NDC 45802096272), effective Nov 11, 2026.

How has the price of ERY 2% PADS changed over time?

Over the history we have for it, the NADAC for ERY 2% PADS has risen 23.5%. It has been tracked across 390 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for ERY 2% PADS?

Since Nov 28, 2013, the NADAC for ERY 2% PADS has ranged from a low of $0.8571 (May 17, 2017) to a high of $1.2428 (Nov 11, 2026), with a median of $1.0084 per EA.

Are there cheaper alternatives to ERY 2% PADS?

No other NADAC-published product currently shares the active ingredient and strength of ERY 2% PADS in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures ERY 2% PADS?

ERY 2% PADS (NDC 45802096272) is labeled by Padagis Israel Pharmaceuticals Ltd, and CMS classifies it as a generic product.